[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334224-105":59,"doc-detail-334224-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oncogenic-ras-in-cancers-from-the-dna-replication-stress-and-senescence-perspective-review","Oncogenic RAS in Cancers from the DNA Replication Stress and Senescence Perspective - Review","","Rat Sarcoma (RAS)-driven cancers are a central concern in cancer biology, yet effective targeting of RAS-mutated disease remains challenging. This review explains how oncogenic RAS reshapes DNA replication and the DNA damage response (DDR) pathways, with emphasis on lung cancers. It connects these molecular events to cytosolic DNA accumulation, innate immune activation, and cellular senescence. The article also outlines potential therapeutic strategies targeting DNA replication, DNA repair, and the cGAS-STING pro-inflammatory pathway, including rationale for combination approaches to improve efficacy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncogenic-ras-in-cancers-from-the-dna-replication-stress-and-senescence-perspective-review/334224/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncogenic-ras-in-cancers-from-the-dna-replication-stress-and-senescence-perspective-review/334224.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What makes RAS-driven cancers difficult to treat?","Question",{"text":112,"@type":113},"Despite major advances in understanding RAS biology, the method to target RAS-mutated cancers is still unclear, making effective therapy a persistent challenge.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does oncogenic RAS affect DNA replication and genome stability?",{"text":117,"@type":113},"The review systematically describes how RAS-mediated alterations impact DNA replication and the DNA damage response (DDR) pathways, promoting genome instability.",{"name":119,"@type":110,"acceptedAnswer":120},"Which therapeutic angles does the review propose for RAS-mutated lung cancers?",{"text":121,"@type":113},"Potential strategies include targeting DNA replication and DNA repair and interfering with the cGAS-STING pro-inflammatory pathway, with emphasis on combination approaches to enhance efficacy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334224,1790013153,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Review  \nOncogenic RAS in Cancers from the DNA Replication Stress and Senescence Perspective  \nHervé Técher 1, *, Samira Kemiha 1, Xieraili Aobuli 2 and Arun Mouli Kolinjivadi 3, *  \nCitation: Técher, H.; Kemiha, S.; Aobuli, X.; Kolinjivadi, A.M. Oncogenic RAS in Cancers from the DNA Replication Stress and Senescence Perspective. Cancers 2024, 16, 3993. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cancers16233993  \nAcademic Editors: Weidong Han and Yubin Zhou  \nReceived: 11 September 2024  \nRevised: 15 November 2024  \nAccepted: 24 November 2024  \nPublished: 28 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Université Côte d’Azur, Institute for Research on Cancer and Aging of Nice—IRCAN, CNRS, INSERM, 06100 Nice, France  \n2 Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA  \n3 Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore  \n* [Correspondence: herve.techer@univ-cotedazur.fr](Correspondence: herve.techer@univ-cotedazur.fr) (H.T.); [arunk.kc@nus.edu.sg](arunk.kc@nus.edu.sg) (A.M.K.)  \nSimple Summary: Oncogenes are proteins promoting cancer formation. Cancers caused by mutations in the RAS oncogene have been a major focus of cancer research for decades. Despite better understanding of how the RAS oncogene works, finding an effective way to treat RAS-driven cancers remains a challenge. This review explores how RAS affects DNA replication and genome stability. It also describes how RAS can lead to inflammatory responses and senescence. Finally, we discuss how these molecular insights have led to potential new lines of treatments to target RAS-mutated cancers.  \nAbstract: Rat Sarcoma (RAS)-driven cancers have been one of the main foci in the field of cancer science for over four decades. Despite significant improvement in understanding the biology of RAS oncogene, the method to target RAS-mutated cancers is still unclear. In recent years, the role for RAS beyond its hyperproliferation has been extensively documented. In this review, we systematically address and dwell on the details of the mechanisms of RAS oncogene-mediated alteration in the DNA replication and DNA damage response (DDR) pathways, focusing on lung cancers. We further extend this molecular connection towards cytosolic DNA accumulation, innate immune activation and senescence in RAS-addicted cancers. At the end, we briefly speculate on the potential strategies for targeting RAS mutated lung cancers, considering various approaches targeting DNA replication, DNA repair and the cGAS-STING pro-inflammatory pathway. These new lines of therapy, especially when used in combinations, may enhance treatment efficacy and overcome the challenges associated with these mutations.  \nKeywords: cancers; RAS; genomic instability; senescence; DNA replication; DNA damage response  \n1. Introduction  \nCancers can be described in broad terms as the acquisition over time of genetic alterations that lead to uncontrolled proliferation and the incapacity to eliminate these aberrant sub-populations of cells. These concepts are best explained in the classical ‘Hallmarks of cancer’ which when first postulated in the year 2000 brought to light ‘six essential alterations in cell physiology that collectively dictate malignant growth’ [1] . Among those six, four essential properties that define cancers are, for instance: ‘self-sufficiency in growth signals, insensitivity to growth-inhibitory (antigrowth) signals, evasion of programmed cell death (apoptosis), limitless replicative potential’ [1] . The acquisition of these hallmarks during tumor formation depends primaril","cbCairLtOtCabRUT","https://ap.wps.com/l/cbCairLtOtCabRUT","pdf",3332852,"English","# Introduction\n## Oncogenes, tumor suppressors, and cancer hallmarks\n## DNA damage response and genomic instability\n## Inflammation, immune response, and therapy development\n# RAS as a driver of genome instability and senescence","[{\"question\":\"What makes RAS-driven cancers difficult to treat?\",\"answer\":\"Despite major advances in understanding RAS biology, the method to target RAS-mutated cancers is still unclear, making effective therapy a persistent challenge.\"},{\"question\":\"How does oncogenic RAS affect DNA replication and genome stability?\",\"answer\":\"The review systematically describes how RAS-mediated alterations impact DNA replication and the DNA damage response (DDR) pathways, promoting genome instability.\"},{\"question\":\"Which therapeutic angles does the review propose for RAS-mutated lung cancers?\",\"answer\":\"Potential strategies include targeting DNA replication and DNA repair and interfering with the cGAS-STING pro-inflammatory pathway, with emphasis on combination approaches to enhance efficacy.\"}]","Oncogenic RAS in Cancers from the DNA Replication Stress and Senescence Perspective - Review | PDF",1790005827,48]